Literature DB >> 10572092

Lymphoid-restricted development from multipotent candidate murine stem cells: distinct and complimentary functions of the c-kit and flt3-ligands.

O J Borge1, J Adolfsson, A Mårtensson, I L Mårtensson, S E Jacobsen.   

Abstract

The two tyrosine kinase receptors, c-kit and flt3, and their respective ligands KL and FL, have been demonstrated to play key and nonredundant roles in regulating the earliest events in hematopoiesis. However, their precise roles and potential interactions in promoting early lymphoid commitment and development remain unclear. Here we show that most if not all murine Lin(-/lo)Sca1(+)c-kit(+) bone marrow (BM) cells generating B220(+)CD19(+) proB-cells in response to FL and interleukin-7 (IL-7) also have a myeloid potential. In contrast to FL + IL-7, KL + IL-7 could not promote proB-cell formation from Lin(-/lo)Sca1(+)c-kit(+) cells. However, KL potently enhanced FL + IL-7-stimulated proB-cell formation, in part through enhanced recruitment of FL + IL-7-unresponsive Lin(-/lo)Sca1(+)c-kit(+) progenitors, and in part by enhancing the growth of proB-cells. The enhanced recruitment (4-fold) in response to KL occurred exclusively from the Lin(-/lo)Sca1(+)c-kit(+)flt3(-) long-term repopulating stem cell population, whereas KL had no effect on FL + IL-7-stimulated recruitment of Lin(-/lo)Sca1(+)c-kit(+)flt3(+) short-term repopulating cells. The progeny of FL + IL-7-stimulated Lin(-/lo)Sca1(+)c-kit(+) cells lacked in vitro and in vivo myeloid potential, but efficiently reconstituted both B and T lymphopoiesis. In agreement with this FL, but not KL, efficiently induced expression of B220 and IL-7 receptor-alpha on Lin(-/lo)Sca1(+)c-kit(+)flt3(+) cells. Thus, whereas KL appears crucial for recruitment of FL + IL-7-unresponsive candidate (c-kit(+)flt3(-)) murine stem cells, FL is essential and sufficient for development toward lymphoid restricted progenitors from a population of (c-kit(+)flt3(+)) multipotent short-term reconstituting progenitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572092

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Contingent gene regulatory networks and B cell fate specification.

Authors:  Harinder Singh; Kay L Medina; Jagan M R Pongubala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

2.  Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment.

Authors:  Melissa L Holmes; Sebastian Carotta; Lynn M Corcoran; Stephen L Nutt
Journal:  Genes Dev       Date:  2006-04-15       Impact factor: 11.361

3.  c-Myb is required for pro-B cell differentiation.

Authors:  Shawn P Fahl; Rowena B Crittenden; David Allman; Timothy P Bender
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

4.  Asynchronous lineage priming determines commitment to T cell and B cell lineages in fetal liver.

Authors:  Claire Berthault; Cyrille Ramond; Odile Burlen-Defranoux; Guillaume Soubigou; Sylvestre Chea; Rachel Golub; Pablo Pereira; Paulo Vieira; Ana Cumano
Journal:  Nat Immunol       Date:  2017-08-21       Impact factor: 25.606

5.  Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors.

Authors:  Robert S Welner; Rosana Pelayo; Karla P Garrett; Xinrong Chen; S Scott Perry; Xiao-Hong Sun; Barbara L Kee; Paul W Kincade
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

6.  Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.

Authors:  Gang G Wang; Martina P Pasillas; Mark P Kamps
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

7.  IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow.

Authors:  Yasmin Khan Parrish; Ineavely Baez; Terry-Ann Milford; Abigail Benitez; Nicholas Galloway; Jaqueline Willeman Rogerio; Eva Sahakian; Mercy Kagoda; Grace Huang; Qian-Lin Hao; Yazmar Sevilla; Lora W Barsky; Ewa Zielinska; Mary A Price; Nathan R Wall; Sinisa Dovat; Kimberly J Payne
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Lineage specification and plasticity in CD19- early B cell precursors.

Authors:  Lynn L Rumfelt; Yan Zhou; Benjamin M Rowley; Susan A Shinton; Richard R Hardy
Journal:  J Exp Med       Date:  2006-02-27       Impact factor: 14.307

9.  Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts.

Authors:  Masanori Onda; Kamran Ghoreschi; Scott Steward-Tharp; Craig Thomas; John J O'Shea; Ira H Pastan; David J FitzGerald
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.426

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.